Continuous purification of therapeutics—removing critical barriers in manufacturing by MCSGP

Triple yield at target purity while reducing buffer (solvent) consumption by up to 70% using a new GMP production scale HPLC system enabled with the patented MCSGP technology. A 30 minute presentation followed by interactive Q&A session on this fast emerging technology for purification of drug therapies and vaccines.